1. Home
  2. KVHI vs TARA Comparison

KVHI vs TARA Comparison

Compare KVHI & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KVH Industries Inc.

KVHI

KVH Industries Inc.

HOLD

Current Price

$9.09

Market Cap

188.0M

Sector

Technology

ML Signal

HOLD

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

HOLD

Current Price

$4.06

Market Cap

214.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVHI
TARA
Founded
1978
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
188.0M
214.7M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
KVHI
TARA
Price
$9.09
$4.06
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$24.40
AVG Volume (30 Days)
341.2K
795.0K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
38.25
EPS
0.03
N/A
Revenue
$9,622,000.00
$2,948,000.00
Revenue This Year
$28.90
N/A
Revenue Next Year
$31.85
N/A
P/E Ratio
$294.83
N/A
Revenue Growth
3.82
N/A
52 Week Low
$5.09
$2.97
52 Week High
$13.00
$7.82

Technical Indicators

Market Signals
Indicator
KVHI
TARA
Relative Strength Index (RSI) 48.69 44.93
Support Level $8.80 $3.62
Resistance Level $9.71 $4.23
Average True Range (ATR) 0.72 0.23
MACD 0.06 0.05
Stochastic Oscillator 55.84 64.96

Price Performance

Historical Comparison
KVHI
TARA

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Share on Social Networks: